Support and Resistance Levels
Past performance
About Pfizer Ltd Pfizer Limited is a prominent pharmaceutical company engaged in the manufacturing, marketing, trading, and export of pharmaceutical products globally. With a robust portfolio of 150 specialized medicines across 15 therapeutic areas, the company operates in six primary therapeutic domains: Internal Medicine, Oncology, Hospital, Vaccines, Inflammation & Immunology, and Rare Diseases. It has manufacturing facilities in Goa and Thane, India, and sells products in 185 countries with 43 manufacturing sites worldwide. Pfizer Limited made its Indian market entry in 1950 and has since developed a significant research and development presence, being the first pharmaceutical company in India to initiate clinical research.
Over the years, Pfizer Limited has engaged in several strategic mergers and acquisitions to bolster its market position. Notably, in 2014, it completed a merger with Wyeth Limited, placing it among the top 10 pharmaceutical companies in India by market share. The company has undergone various business transformations, including divestitures and strategic partnerships to optimize its product offerings. These strategic moves underscore Pfizer Limited's commitment to innovation and expanding its footprint in the pharmaceutical sector.